Changyang Liu

ORCID: 0000-0003-1132-2470
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Chemical Synthesis and Analysis
  • Click Chemistry and Applications
  • Synthesis and Biological Evaluation
  • Cancer therapeutics and mechanisms
  • Synthesis and pharmacology of benzodiazepine derivatives
  • Sulfur-Based Synthesis Techniques

Chongqing University
2022-2023

The incorporation of the isoindole core into DNA-encoded chemical library is highly desirable for great potential pharmacological characters exampled by molecules like lenalidomide. Herein, we reported a DNA-compatible protocol OPA-mediated transformation amines drug-like moieties represented isoindolinone and thio-2-isoindole, respectively. high conversion wide substrate-scope property our render its feasibility in manipulation terminal on oligonucleotide conjugates, including...

10.1021/acs.joc.1c02496 article EN The Journal of Organic Chemistry 2022-01-25

Taking advantage of aryl diazonium intermediates, this work reported a DNA-compatible C–C bond formation strategy, achieving broad substrate scope, exquisite functional group tolerance, and orthogonality to halide-based coupling reactions.

10.1039/d2sc04482j article EN cc-by Chemical Science 2022-01-01

The incorporation of N-containing heterocycles with potential bioactivity into DNA-encoded chemical libraries (DELs) represents an important approach to synthesizing medicinally useful compound collections for high-throughput screening. Herein, we reported a synthetic methodology afford benzotriazinone core as drug-like scaffold in DNA-compatible manner through aryl diazonium intermediates. Starting from DNA-conjugated amines, anthranilic acid or isatoic anhydride building blocks were...

10.1021/acs.joc.2c02686 article EN The Journal of Organic Chemistry 2023-05-22

DNA-compatible combinatorial synthetic reaction allowed the introduction of pharmaceutically privileged 2-thiobenzimidazole and 2-thiobenzoxazole scaffold.

10.1039/d3cc02593d article EN Chemical Communications 2023-01-01
Coming Soon ...